Does ActiPatch® Work? What the Evidence Says
By Electrome Corporation · Published September 26, 2026
ActiPatch® has published evidence on pain relief, but a study result cannot predict your own outcome. It is FDA 510(k) cleared (K192234) as an over-the-counter adjunctive treatment of musculoskeletal pain. This guide explains what the trials, registries, and clearance record can and cannot tell you.
Where each kind of evidence fits
FDA clearance
Shows the device was reviewed for its cleared use. It does not promise a result for you.
Trials
Compare a group using the device with a group that is not. They describe study groups.
Registries
Collect what users report. They cannot show cause and effect.
Your own notes
Write down where you wore it and how your days felt. Share them with your clinician.
What do the randomized trials report?
Double-blind, placebo-controlled trials (neither the people nor the researchers knew who had the real device) in knee osteoarthritis (Bagnato, 2016) and plantar fasciitis (Brook, 2012) reported less pain in their study groups. They measured pain. They did not measure changes to the underlying condition.
See each trial's findings on the Science pageWhat about neck and back pain evidence?
An open-label neck osteoarthritis trial, where everyone knew what they were using, compared ActiPatch® with an NSAID (a type of anti-inflammatory medicine). User registries describe reported experience and have no placebo group. Neither shows that ActiPatch® is better or proves a cause.
Read how to weigh trials and registriesWhat exactly does FDA clearance mean?
The U.S. record is FDA 510(k) K192234. FDA reviewed ActiPatch® through the 510(k) premarket notification route, which is used for devices like it. It cleared ActiPatch® for over-the-counter adjunctive treatment of musculoskeletal pain. Adjunctive means you can use it alongside other treatments, but do not stop or change prescribed care without talking to your healthcare professional. Clearance describes the cleared use. It is not a promise of benefit for you. You can see the record in FDA’s public 510(k) database.
A cleared use is also not permission to say ActiPatch® corrects a diagnosis. When our site discusses knee osteoarthritis or plantar fasciitis, it means relief of the related musculoskeletal pain. The device is drug-free and nonthermal. That does not mean everyone will tolerate it or find it useful.
Why can different users have different results?
People differ in where their pain is, how long they have had it, what causes it, and what else they use. Even a well-run trial reports an average for its participants, not a forecast for you. If you try a device, note where you put it, how long you wore it and how pain affected your day. Talk to a clinician about pain that lasts or gets worse. A product page cannot diagnose you.
Follow the package directions. Put the loop over the painful area, on skin with the included tape or a wrap, or over thin clothing. Avoid thick fabric. Keep the device dry. Do not use it with a pacemaker or ICD, another implanted electronic device, or if you are or may be pregnant.
A practical reading of the evidence
The evidence supports a careful question: might adjunctive PSWT help pain for someone like the people studied? It does not support a blanket promise. Read the original papers and their methods, read the clearance record, and decide with your clinician how to judge your own experience. Our science page links to the evidence and explains the difference between a trial and a registry.
Frequently asked questions
Is ActiPatch® FDA approved?
ActiPatch® is FDA cleared (510(k) K192234) for over-the-counter adjunctive treatment of musculoskeletal pain. FDA reviewed it through the 510(k) premarket notification pathway, the route used for devices like ActiPatch®, and it can be used alongside other treatments.
Are the back-pain registry findings from an RCT?
No. Staelin’s 2017 chronic back-pain registry is observational and cannot alone establish a causal effect.
Will ActiPatch® relieve my pain?
Individual results vary. Published studies describe their populations, not a guaranteed outcome for every person.
Primary sources
Educational information only. ActiPatch® is FDA 510(k) cleared (K192234) for over-the-counter (OTC) adjunctive treatment of musculoskeletal pain. Read the package instructions and consult a clinician about persistent or worsening pain.